ablation prediction software (Philips Healthcare)
Structured Review
Ablation Prediction Software, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/predict+software/ablation+prediction+software/pm41222632-14474-4-11
Average 86 stars, based on 1 article reviews
Images
Related Articles
Software:Article Title: CIRSE 2025 Book of Abstracts. Article Snippet: s of ORAL PRESENTATIONS September 13-17 Barcelona, Spain CIRSE 2025 CIRSE 2025 – Abstract Book Cardiovascular and Interventional Radiological Society of Europe 2 55936 (author index ID) 131.1 / New insights into the 12 months outcomes from the SUCCESS PTA study – a stratified analysis by lesion location of the performance of a novel sirolimus-eluting balloon in real-world patients with peripheral arterial disease Lichtenberg M 1Vascular Centre Clinic Arnsberg, Arnsberg, Germany Purpose: Lesion location in peripheral artery disease (PAD) is a key factor in determining clinical outcomes, particularly in terms of revascularization and long-term limb salvage.. The objective is to evaluate the performance of SELUTION SLRTM sirolimus-eluting balloon in PAD patients stratified by lesion location.. Methodology: SUCCESS PTA study is a prospective, multi-center, single-arm post-market study of the SELUTION SLRTM for treatment of above and below-the-knee lesions. Injection:Article Title: CIRSE 2025 Book of Abstracts. Article Snippet: s of ORAL PRESENTATIONS September 13-17 Barcelona, Spain CIRSE 2025 CIRSE 2025 – Abstract Book Cardiovascular and Interventional Radiological Society of Europe 2 55936 (author index ID) 131.1 / New insights into the 12 months outcomes from the SUCCESS PTA study – a stratified analysis by lesion location of the performance of a novel sirolimus-eluting balloon in real-world patients with peripheral arterial disease Lichtenberg M 1Vascular Centre Clinic Arnsberg, Arnsberg, Germany Purpose: Lesion location in peripheral artery disease (PAD) is a key factor in determining clinical outcomes, particularly in terms of revascularization and long-term limb salvage.. The objective is to evaluate the performance of SELUTION SLRTM sirolimus-eluting balloon in PAD patients stratified by lesion location.. Methodology: SUCCESS PTA study is a prospective, multi-center, single-arm post-market study of the SELUTION SLRTM for treatment of above and below-the-knee lesions. |
